Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barney S Graham

Showing results (141-150 of 420) with videos related to

Pageof 42
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2005
Allergen-induced airway hyperresponsiveness mediated by cyclooxygenase inhibition is not dependent on 5-lipoxygenase or IL-5, but is IL-13 dependentR Stokes Peebles, Koichi Hashimoto, James R Sheller, et al.
Vaccine|February 10, 2023
A multivalent polyomavirus vaccine elicits durable neutralizing antibody responses in macaquesAlberto Peretti, Diana G Scorpio, Wing-Pui Kong, et al.
Journal of Virology|July 10, 2015
Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine CandidateBo Liang, Sonja Surman, Emerito Amaro-Carambot, et al.
Plos Pathogens|July 3, 2013
HIV-1 vaccine-induced T-cell responses cluster in epitope hotspots that differ from those induced in natural infection with HIV-1Tomer Hertz, Hasan Ahmed, David P Friedrich, et al.
Science Translational Medicine|December 21, 2022
A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccineLauren A Chang, Emily Phung, Michelle C Crank, et al.
AIDS Research and Human Retroviruses|May 27, 2014
The immune space: a concept and template for rationalizing vaccine developmentAmapola Manrique, Elizabeth Adams, Dan H Barouch, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2004
Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5Koichi Hashimoto, Barney S Graham, Samuel B Ho, et al.
Virology|March 21, 2009
High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccinationKatie L Davis, Elin S Gray, Penny L Moore, et al.
Plos One|March 14, 2014
Phase I randomized clinical trial of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular (i.m.), subcutaneous (s.c.) and intradermal (i.d.) administration (VRC 011)Mary E Enama, Julie E Ledgerwood, Laura Novik, et al.
Journal of Virology|June 10, 2016
A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton RatsChristina A Rostad, Christopher C Stobart, Brian E Gilbert, et al.
Pageof 42

Showing results (141-150 of 420) with videos related to

Sort By:
Pageof 42
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2005
Allergen-induced airway hyperresponsiveness mediated by cyclooxygenase inhibition is not dependent on 5-lipoxygenase or IL-5, but is IL-13 dependentR Stokes Peebles, Koichi Hashimoto, James R Sheller, et al.
Vaccine|February 10, 2023
A multivalent polyomavirus vaccine elicits durable neutralizing antibody responses in macaquesAlberto Peretti, Diana G Scorpio, Wing-Pui Kong, et al.
Journal of Virology|July 10, 2015
Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine CandidateBo Liang, Sonja Surman, Emerito Amaro-Carambot, et al.
Plos Pathogens|July 3, 2013
HIV-1 vaccine-induced T-cell responses cluster in epitope hotspots that differ from those induced in natural infection with HIV-1Tomer Hertz, Hasan Ahmed, David P Friedrich, et al.
Science Translational Medicine|December 21, 2022
A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccineLauren A Chang, Emily Phung, Michelle C Crank, et al.
AIDS Research and Human Retroviruses|May 27, 2014
The immune space: a concept and template for rationalizing vaccine developmentAmapola Manrique, Elizabeth Adams, Dan H Barouch, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2004
Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5Koichi Hashimoto, Barney S Graham, Samuel B Ho, et al.
Virology|March 21, 2009
High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccinationKatie L Davis, Elin S Gray, Penny L Moore, et al.
Plos One|March 14, 2014
Phase I randomized clinical trial of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular (i.m.), subcutaneous (s.c.) and intradermal (i.d.) administration (VRC 011)Mary E Enama, Julie E Ledgerwood, Laura Novik, et al.
Journal of Virology|June 10, 2016
A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton RatsChristina A Rostad, Christopher C Stobart, Brian E Gilbert, et al.
Pageof 42